Prophase labs reports financial results for the three and nine months ended september 30, 2020

Doylestown, pennsylvania, nov. 16, 2020 (globe newswire) -- prophase labs, inc. (nasdaq: prph), a diversified medical science and technology company, today announced net sales of $3.8 million for the three months ended september 30, 2020, compared to net sales of $2.8 million for the three months ended september 30, 2019. the company incurred a net loss from continued operations for the three months ended september 30, 2020 of $569,000, or ($0.05) per share, compared to a net loss from continued operations of $428,000, or ($0.04) per share, for the three months ended september 30, 2019. for the three months ended september 30, 2020, the company also recognized income from discontinued operations of $161,000, or $0.01 per share. the company incurred a net loss for the three months ended september 30, 2020 of $408,000, or ($0.04) per share, compared to a net loss of $428,000, or ($0.04) per share, for the three months ended september 30, 2019.
PRPH Ratings Summary
PRPH Quant Ranking